Clinical Trials · NCT01507038
Safety and Efficacy of YH14617 in Diabetes Mellitus
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Yuhan Corporation
- Enrollment
- 84
- Start date
- Dec 2011
- Locations
- 1 site, South Korea
- Primary endpoint
- Change from baseline in HbA1c at week 12